GlobeNewswire: Fondation de l’Institut de Cardiologie de Montréal Contains the last 10 of 20 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T02:37:11ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2022/11/08/2550721/0/en/National-study-suggests-it-s-time-to-rethink-how-we-treat-atrial-fibrillation.html?f=22&fvtc=4&fvtv=54958National study suggests it’s time to rethink how we treat atrial fibrillation2022-11-08T12:00:00Z<![CDATA[Montreal, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Doctors researchers from the Montreal Heart Institute (MHI) presented new data today at the American Heart Association Late-Breaking Scientific Sessions. Simultaneously published in the New England Journal of Medicine, the data shows that catheter ablation may be better than antiarrhythmic drugs at halting disease progression.]]>Montreal Heart InstituteMontreal Heart Institutehttps://www.globenewswire.com/news-release/2022/11/07/2550305/0/en/National-study-suggests-it-s-time-to-rethink-how-we-treat-atrial-fibrillation.html?f=22&fvtc=4&fvtv=54958National study suggests it’s time to rethink how we treat atrial fibrillation2022-11-07T21:32:42Z<![CDATA[Montreal, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Doctors researchers from the Montreal Heart Institute (MHI) presented new data today at the American Heart Association Late-Breaking Scientific Sessions. Simultaneously published in the New England Journal of Medicine, the data shows that catheter ablation may be better than antiarrhythmic drugs at halting disease progression.]]>Montreal Heart InstituteMontreal Heart Institutehttps://www.globenewswire.com/news-release/2020/04/07/2012897/0/en/New-clinical-trial-for-treatment-of-COVID-19-positive-patients-to-start-at-NYU-Grossman-School-of-Medicine-in-partnership-with-Montreal-Heart-Institute.html?f=22&fvtc=4&fvtv=54958New clinical trial for treatment of COVID-19 positive patients to start at NYU Grossman School of Medicine in partnership with Montreal Heart Institute2020-04-07T13:22:15Z<![CDATA[COLCORONA trial to examine whether colchicine can reduce complications associated with COVID-19, slow disease progression, and save patient lives COLCORONA trial to examine whether colchicine can reduce complications associated with COVID-19, slow disease progression, and save patient lives]]>https://www.globenewswire.com/news-release/2020/04/06/2012467/0/fr/D%C3%A9but-du-nouvel-essai-clinique-pour-le-traitement-des-patients-diagnostiqu%C3%A9s-positifs-%C3%A0-la-COVID-19-%C3%A0-l-%C3%89cole-de-m%C3%A9decine-Grossman-de-l-Universit%C3%A9-de-New-York-en-partenariat-avec-l.html?f=22&fvtc=4&fvtv=54958Début du nouvel essai clinique pour le traitement des patients diagnostiqués positifs à la COVID-19 à l’École de médecine Grossman de l’Université de New York, en partenariat avec l’Institut de Cardiologie de Montréal2020-04-06T21:35:12Z<![CDATA[L’étude clinique COLCORONA vise à déterminer si la colchicine peut réduire les complications associées à la COVID-19, ralentir la progression de la maladie et sauver la vie de patients. L’étude clinique COLCORONA vise à déterminer si la colchicine peut réduire les complications associées à la COVID-19, ralentir la progression de la maladie et sauver la vie de patients.]]>https://www.globenewswire.com/news-release/2020/04/03/2011644/0/en/Sophie-Desmarais-donates-1-million-for-research-at-the-Montreal-Heart-Institute.html?f=22&fvtc=4&fvtv=54958Sophie Desmarais donates $1 million for research at the Montreal Heart Institute2020-04-03T17:43:08Z<![CDATA[Launch of a major fundraising challenge to support important discoveries Launch of a major fundraising challenge to support important discoveries]]>Sophie DesmaraisSophie Desmaraishttps://www.globenewswire.com/news-release/2020/04/03/2011644/0/fr/Don-de-1M-de-Sophie-Desmarais-pour-la-recherche-%C3%A0-l-Institut-de-Cardiologie-de-Montr%C3%A9al.html?f=22&fvtc=4&fvtv=54958Don de 1M$ de Sophie Desmarais pour la recherche à l’Institut de Cardiologie de Montréal2020-04-03T17:43:08Z<![CDATA[Lancement d’un grand défi philanthropique pour soutenir des découvertes majeures Lancement d’un grand défi philanthropique pour soutenir des découvertes majeures]]>Sophie DesmaraisSophie Desmaraishttps://www.globenewswire.com/news-release/2020/03/27/2007716/0/en/Message-of-public-interest-Clinical-study-for-people-infected-with-COVID-19.html?f=22&fvtc=4&fvtv=54958Message of public interest: Clinical study for people infected with COVID-192020-03-27T14:25:14Z<![CDATA[Looking for 6000 participants Looking for 6000 participants]]>https://www.globenewswire.com/news-release/2020/03/27/2007716/0/fr/Message-d-int%C3%A9r%C3%AAt-public-%C3%89tude-clinique-pour-les-personnes-infect%C3%A9es-au-COVID-19.html?f=22&fvtc=4&fvtv=54958Message d’intérêt public : Étude clinique pour les personnes infectées au COVID-192020-03-27T14:25:14Z<![CDATA[6000 participants recherchés 6000 participants recherchés]]>https://www.globenewswire.com/news-release/2020/03/23/2004754/0/en/New-clinical-study-Potential-treatment-for-coronavirus-will-be-tested-in-Canada-as-of-today.html?f=22&fvtc=4&fvtv=54958New clinical study: Potential treatment for coronavirus will be tested in Canada as of today2020-03-23T12:32:46Z<![CDATA[MONTREAL, March 23, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute announces that its Research Center is launching today a COVID-19 clinical study in Canada to determine whether short-term treatment would reduce the risk of pulmonary complications and related deaths.]]>https://www.globenewswire.com/news-release/2020/03/23/2004754/0/fr/Nouvelle-%C3%A9tude-clinique-Un-traitement-potentiel-du-coronavirus-sera-test%C3%A9-au-Canada-d%C3%A8s-maintenant.html?f=22&fvtc=4&fvtv=54958Nouvelle étude clinique : Un traitement potentiel du coronavirus sera testé au Canada dès maintenant2020-03-23T12:32:46Z<![CDATA[MONTRÉAL, 23 mars 2020 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal annonce que son Centre de recherche lance dès aujourd’hui une étude clinique canadienne afin de déterminer si un traitement à court terme réduirait le risque de complications pulmonaires et de décès liés à la COVID-19.]]>